Table 3

Co-existence of IBS, gastro-oesophageal reflux symptoms and BHR

Observed prevalence (95% CI) Expected prevalence (95% CI)
Male1.65% (1.57–1.73)0.41% (0.39–0.43)
Female3.20% (3.05–3.35)0.94% (0.90–0.98)
Total2.49% (2.41–2.57)0.68% (0.66–0.71)
  • CI, confidence interval.